HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma

Christine Desmedt 1 Roberto Salgado 1 Marco Fornili 2 Giancarlo Pruneri 3 Gert van den Eynden Gabriele Zoppoli 4 Françoise Rothé Laurence Buisseret Soizic Garaud 5 Karen Willard-Gallo 6 David Brown 7 Yacine Bareche 8 Ghizlane Rouas 6 Christine Galant 9 Sherene Loi 1 Giuseppe Viale 10 Angelo Di Leo 11 Andrew Green 12 Ian Ellis Emad Rakha Denis Larsimont Elia Biganzoli Christos Sotiriou Thomas Brodowicz 13 Olivier Mir 14 Jennifer Wallet 15 Antoine Italiano 16 Jean-Yves Blay 17 François Bertucci 18 Wolfgang Eisterer Christine Chevreau 19 Sophie Piperno-Neumann 20 Emmanuelle Bompas 21 Thomas Ryckewaert 22 Bernadette Liegl-Antzwager Julien Thery 23 Nicolas Penel 24 Axel Le Cesne 14 Marie-Cécile Le Deley
Document type :
Journal articles
Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-03623702
Contributor : François Bertucci Connect in order to contact the contributor
Submitted on : Tuesday, March 29, 2022 - 6:38:29 PM
Last modification on : Tuesday, May 17, 2022 - 2:20:03 PM

Identifiers

Citation

Christine Desmedt, Roberto Salgado, Marco Fornili, Giancarlo Pruneri, Gert van den Eynden, et al.. Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma. European Journal of Cancer, Elsevier, 2018, 99 (7), pp.28-36. ⟨10.1016/j.ejca.2018.05.008⟩. ⟨hal-03623702⟩

Share

Metrics

Record views

9